Repeated, low-dose oral esketamine in patients with treatment-resistant depression: pilot study
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Repeated, low-dose oral esketamine in patients with treatment-resistant depression: pilot study
Authors
Keywords
-
Journal
BJPsych Open
Volume 8, Issue 1, Pages -
Publisher
Royal College of Psychiatrists
Online
2021-12-06
DOI
10.1192/bjo.2021.1059
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation
- (2021) Roger S. McIntyre et al. AMERICAN JOURNAL OF PSYCHIATRY
- Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liability
- (2021) Jordi Bonaventura et al. MOLECULAR PSYCHIATRY
- Intravenous arketamine for treatment-resistant depression: open-label pilot study
- (2020) Gustavo C. Leal et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Efficacy of single and repeated administration of ketamine in unipolar and bipolar depression: a meta-analysis of randomized clinical trials
- (2020) Joanna Kryst et al. Pharmacological Reports
- Cost-Effectiveness of Esketamine Nasal Spray for Patients With Treatment-Resistant Depression in the United States
- (2020) Eric L. Ross et al. PSYCHIATRIC SERVICES
- A Word to the Wise About Intranasal Esketamine
- (2019) Alan F. Schatzberg AMERICAN JOURNAL OF PSYCHIATRY
- Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial
- (2019) Sanne Y. Smith-Apeldoorn et al. BMC Psychiatry
- AMPA Receptor Activation–Independent Antidepressant Actions of Ketamine Metabolite ( S )-Norketamine
- (2018) Chun Yang et al. BIOLOGICAL PSYCHIATRY
- Does oral administration of ketamine accelerate response to treatment in major depressive disorder? Results of a double-blind controlled trial
- (2018) Somaye Arabzadeh et al. JOURNAL OF AFFECTIVE DISORDERS
- The neurobiology of depression, ketamine and rapid-acting antidepressants: Is it glutamate inhibition or activation?
- (2018) Chadi G. Abdallah et al. PHARMACOLOGY & THERAPEUTICS
- Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study
- (2016) Jaskaran B. Singh et al. BIOLOGICAL PSYCHIATRY
- Oral ketamine for the treatment of pain and treatment-resistant depression
- (2016) Robert A. Schoevers et al. BRITISH JOURNAL OF PSYCHIATRY
- Validation of the 17-item Hamilton Depression Rating Scale definition of response for adults with major depressive disorder using equipercentile linking to Clinical Global Impression scale ratings: analysis of Pharmacogenomic Research Network Antidepressa
- (2016) William V. Bobo et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Efficacy and safety of oral ketamine versus diclofenac to alleviate mild to moderate depression in chronic pain patients: A double-blind, randomized, controlled trial
- (2016) Morteza Jafarinia et al. JOURNAL OF AFFECTIVE DISORDERS
- Single-dose infusion ketamine and non-ketamine N-methyl-d-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories
- (2016) T. Kishimoto et al. PSYCHOLOGICAL MEDICINE
- Population pharmacokinetics of S-ketamine and norketamine in healthy volunteers after intravenous and oral dosing
- (2015) Samuel Fanta et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Antidepressant, mood stabilizing and procognitive effects of very low dose sublingual ketamine in refractory unipolar and bipolar depression
- (2013) Diogo R. Lara et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Relapse Following Successful Electroconvulsive Therapy for Major Depression: A Meta-Analysis
- (2013) Ana Jelovac et al. NEUROPSYCHOPHARMACOLOGY
- Sub-anesthetic concentrations of (R,S)-ketamine metabolites inhibit acetylcholine-evoked currents in α7 nicotinic acetylcholine receptors
- (2012) Ruin Moaddel et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Ketamine use: a review
- (2011) Celia J. A. Morgan et al. ADDICTION
- Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression
- (2009) Marije aan het Rot et al. BIOLOGICAL PSYCHIATRY
- Use of oral ketamine in chronic pain management: A review
- (2009) Maren I. Blonk et al. EUROPEAN JOURNAL OF PAIN
- Oral Administration of the NMDA Receptor Antagonist S-Ketamine as Add-On Therapy of Depression: A Case Series
- (2009) G. Paslakis et al. PHARMACOPSYCHIATRY
- Effects of norketamine enantiomers in rodent models of persistent pain
- (2008) J HOLTMANJR et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More